Constitutive/hypoxic degradation of HIF-α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein

被引:62
|
作者
Kong, Xianguo
Alvarez-Castelao, Beatriz
Lin, Zhao
Castano, Jose G.
Caro, Jaime
机构
[1] Thomas Jefferson Univ, Cardeza Fdn, Philadelphia, PA 19107 USA
[2] UAM, Fac Med, CSIC, Dept Bioquim, Madrid, Spain
[3] UAM, Inst Invest Biomed Alberto Sols, CSIC, Fac Med, Madrid, Spain
关键词
D O I
10.1074/jbc.M700704200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional activator complex HIF-1 plays a key role in the long term adaptation of cells and tissues to their hypoxic microenvironment by stimulating the expression of genes involved in angiogenesis and glycolysis. The expression of the HIF-1 complex is regulated by the levels of its HIF-alpha subunits that are degraded under normoxic conditions by the ubiquitin-proteasome system. Whereas this pathway of HIF-alpha protein degradation has been well characterized, little is known of their turnover during prolonged hypoxic conditions. Herein, we describe a pathway by which HIF-1 alpha and HIF-2 alpha proteins are constitutively degraded during hypoxia by the proteasome system, although without requirement of prior ubiquitylation. The constitutive/hypoxic degradation of HIF-alpha proteins is independent of the presence of VHL, binding to DNA, or the formation of a transcriptionally active HIF-1 complex. These results are further strengthened by the demonstration that HIF-alpha proteins are directly degraded in a reconstituted in vitro assay by the proteasome. Finally, we demonstrate that the persistent down-regulation of HIF-1 alpha during prolonged hypoxia is mainly caused by a decreased production of the protein without change in its degradation rate. This constitutive, ubiquitin-independent proteasomal degradation pathway of HIF-alpha proteins has to be taken into account in understanding the biology as well as in the development of therapeutic interventions of highly hypoxic tumors.
引用
收藏
页码:15498 / 15505
页数:8
相关论文
共 50 条
  • [41] Role of the C-terminal α-helical domain of the von Hippel–Lindau protein in its E3 ubiquitin ligase activity
    Martin D Lewis
    Ben J Roberts
    Oncogene, 2004, 23 : 2315 - 2323
  • [42] Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor gene product
    Pereira, T
    Zheng, XW
    Ruas, JL
    Tanimoto, K
    Poellinger, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) : 6816 - 6823
  • [43] von Hippel-Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step
    Mousnier, Aurelie
    Kubat, Nicole
    Massias-Simon, Aurelie
    Segeral, Emmanuel
    Rain, Jean-Christophe
    Benarous, Richard
    Emiliani, Stephane
    Dargemont, Catherine
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (34) : 13615 - 13620
  • [44] Role of the C-terminal α-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity
    Lewis, MD
    Roberts, BJ
    ONCOGENE, 2004, 23 (13) : 2315 - 2323
  • [45] Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma
    Turcotte, S
    Desrosiers, RR
    Béliveau, R
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (02) : F338 - F348
  • [46] Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein
    Groulx, I
    Lee, S
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) : 5319 - 5336
  • [47] Funktionen des VHL-Proteins bei Entstehung und Progression von NierenzellkarzinomenVon-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer
    H. Moch
    Der Pathologe, 2008, 29 (Suppl 2): : 149 - 152
  • [48] von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms
    Calzada, MJ
    Esteban, MA
    Feijoo-Cuaresma, M
    Castellanos, MC
    Naranjo-Suárez, S
    Temes, E
    Méndez, F
    Yánez-Mo, M
    Ohh, M
    Landázuri, MO
    CANCER RESEARCH, 2006, 66 (03) : 1553 - 1560
  • [49] A patent review of von Hippel-Lindau (VHL)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present)
    Urbina, Aina
    Hallatt, Alex J.
    Robertson, Jack
    Ciulli, Alessio
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 35 (03) : 197 - 238
  • [50] Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene:: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
    Osada, Ryosuke
    Horiuchi, Akiko
    Kikuchi, Norihiko
    Yoshida, Junko
    Hayashi, Akiko
    Ota, Masao
    Katsuyama, Yoshihiko
    Melilo, Giovanni
    Konishi, Ikuo
    HUMAN PATHOLOGY, 2007, 38 (09) : 1310 - 1320